Results 191 to 200 of about 9,108 (204)

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat

Journal of Infectious Diseases, 2021
Guido Ferrari, Joseph J Eron
exaly  

HIV latency reversal agents: A potential path for functional cure?

European Journal of Medicinal Chemistry, 2021
Jean Leandro Dos Santos, Juliana Romano Lopes, Diego Eidy Chiba   +2 more
exaly  

Bioactive Compounds from Euphorbia usambarica Pax. with HIV-1 Latency Reversal Activity

Pharmaceuticals, 2021
Racheal A Nell, Andrea Vasas, Judit Hohmann   +2 more
exaly  

The role of latency reversal in HIV cure strategies

Journal of Medical Primatology, 2022
Michael Roche, Sharon R. Lewin, Youry Kim   +2 more
exaly  

Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency

EBioMedicine, 2021
Thomas A. Rasmussen, Steven G Deeks, Rachel Pascoe   +2 more
exaly  

Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency Reversal

ACS Infectious Diseases, 2020
Edward P Browne, Brian D Strahl
exaly  

Latency Reversal 2.0: Giving the Immune System a Seat at the Table

Current HIV/AIDS Reports, 2021
Ann Chahroudi, Maud Mavigner, Amir Dashti   +2 more
exaly  

Design and synthesis of new hybrid latency reversal agents for HIV treatment

2020
Jean Leandro Dos Santos, Juliana Romano Lopes   +1 more
exaly  

Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.

Journal of Virology, 2018
Mark M Painter, Kathleen L. Collins, Thomas D Zaikos   +2 more
exaly  

Reversal of Latency as Part of a Cure for HIV-1

Trends in Microbiology, 2016
Thomas A. Rasmussen, Martin Tolstrup, Ole Schmeltz Søgaard   +2 more
exaly